WO1992012645A1 - Use of an enzyme containing granulate and method for production of a pelletized fodder - Google Patents

Use of an enzyme containing granulate and method for production of a pelletized fodder Download PDF

Info

Publication number
WO1992012645A1
WO1992012645A1 PCT/DK1992/000026 DK9200026W WO9212645A1 WO 1992012645 A1 WO1992012645 A1 WO 1992012645A1 DK 9200026 W DK9200026 W DK 9200026W WO 9212645 A1 WO9212645 A1 WO 9212645A1
Authority
WO
WIPO (PCT)
Prior art keywords
granulate
fodder
coated
pelletized
coating agent
Prior art date
Application number
PCT/DK1992/000026
Other languages
French (fr)
Inventor
Kim Torben Jacobsen
Poul Erik Jensen
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Priority to EP92904521A priority Critical patent/EP0569468B1/en
Priority to US08/070,402 priority patent/US5391371A/en
Priority to DE69201952T priority patent/DE69201952T2/en
Priority to JP50413192A priority patent/JP3571336B2/en
Publication of WO1992012645A1 publication Critical patent/WO1992012645A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/10Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
    • C12N11/12Cellulose or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/189Enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K40/00Shaping or working-up of animal feeding-stuffs
    • A23K40/20Shaping or working-up of animal feeding-stuffs by moulding, e.g. making cakes or briquettes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K40/00Shaping or working-up of animal feeding-stuffs
    • A23K40/25Shaping or working-up of animal feeding-stuffs by extrusion
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K40/00Shaping or working-up of animal feeding-stuffs
    • A23K40/30Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/80Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
    • Y02P60/87Re-use of by-products of food processing for fodder production

Definitions

  • the invention comprises a use of an enzyme containing granulate and a method for production of a pelletized fodder.
  • fodder it is described that the addition of enzymes to the fodder has a beneficial effect, vide e.g. Hesselman, K. and Aman P., The effect of ⁇ -glucanase on the utilization of starch and nitrogen by broiler chickens fed on barley of low- or high-viscosity. Animal Feed Science and Technology, 15 (1986) 83- 93.
  • pelletizing of the fodder is a desideratum, as pelletizing of the fodder increases the digestibility of especially the starch fraction.
  • pelletizing of the fodder reduces the dust, it makes the fodder easier to eat for the birds, and it makes it possible to incorporate small amounts of ingredients in the fodder and to "lock" the fodder mixture.
  • the process of producing fodder pellets it is considered necessary to heat treat the fodder pellets in order to kill the Salmonella bacteria, whereby a heat treatment to around 80°C is appropriate.
  • the enzymes are not stable at this high temperature, and thus, a large surplus of enzymes has to be used, or enzyme free fodder components have been pelletized and heat treated, whereafter an enzyme containing slurry or solution has been coated on the heat treated pellets.
  • this coating is cumbersome and is often not compatible with existing plants.
  • there is a need for an enzyme containing fodder which can be produced easier and by means of existing fodder producing plants.
  • the art encompassing enzyme containing granulates produced as additives in detergents comprises a socalled T-granulate, produced as indicated in US 4,106,991.
  • a T-granulate which is coated with a wax, a triglyceride or other fat, is described in WO 89/08694, claims 12 and 1, EP 206,417, claims 17, 13, and 1 , and US 4,707,287, claims 1 and 14 and column 9, example II.
  • coated T-granulate has been produced by coating of the T-granulate by a triglyceride instead of the traditional PEG.
  • coated T-granulate is used as an additive in detergents, and to the best of applicant's knowledge this coated T-granulate has not been suggested for other uses than in the detergent field.
  • T-granulate can be used as a component of a mixture, which can be converted to a fodder by treatment with steam and pelletizing without appreciable loss of enzyme activity, in contradistinction to the prior art, in relation to which an appreciable loss of enzyme activity will take place during steam treatment and pelletizing.
  • an enzyme containing T- granulate which is coated with a coating agent comprising a high melting fat or wax is a use as a component of a mixture, which is well suited as a fodder if the mixture is steam treated and subsequently pelletized.
  • a T-granulate is a granulate produced according to US 4,106,991, i.e. a granulate containing 2-40% finely divided cellulose fibres.
  • the T-granulate contains one or more of the enzymes, which can be used as additives to fodders.
  • proteases e.g. from Bacillus, for instance Bacillus licheniformis, xylanases, cellulases, beta-glucanases, e.g. from Bacillus, Humicola, for instance Humicola insolens, or Actinomycetes
  • pectinases e.g.
  • ⁇ -galactosidases e.g. from Aspergillus, for instance Aspergillus niger
  • amylases e.g. from Bacillus, for instance Bacillus subtilis.
  • the coating agent comprises a high melting fat or wax.
  • a high melting fat is a glycerol ester (mono-, di- or triester or a mixture thereof) with a melting point between 30 and 100°C
  • a high melting wax is a waxy substance according to the definition in US 4,106,991 , col. 3, lines 45- 50, i.e. a substance which possesses all of the following characteristics: (1) the melting point is between 30° and 100°C, preferably between 40° and 60°C, (2) the substance is of tough and not brittle nature, and (3) the substance possesses substantial plasticity at room temperature.
  • a preferred embodiment of the use according to the invention is characterized by the fact that the coating agent comprises up to 80%, preferably 60- 75% of a filler, which is a dry powder of any material, preferably an inorganic material, more preferably kaolin, magnesium silicate or calcium carbonate. Incorporation of the indicated filler into the coating agent in the amount indicated will reduce the tendency of the separate granules to adhere to each other and to the granulating apparatus.
  • a filler which is a dry powder of any material, preferably an inorganic material, more preferably kaolin, magnesium silicate or calcium carbonate.
  • a preferred embodiment of the use according to the invention is characterized by the fact that the coating agent constitutes 1-95% w/w, preferably 15-35% w/w of the final, coated T-granulate. If an amount of coating agent below 1 % w/w is used no satisfactory enzyme stability improvement is obtained, and if an amount of coating agent above 95% is used, no further improvement of the enzyme stability is obtained.
  • a preferred embodiment of the use according to the invention is characterized by the fact that the T-granulate on top of the coating is coated once more with a polymeric material, preferably in a fluidized bed. In this manner the enzymatic stability is further improved.
  • the invention comprises a method for production of a pelletized fodder, and this method is characterized by the fact that a mixture of an enzyme containing T-granulate, which is coated with a coating agent comprising a high melting fat or wax, and fodder components, is steam treated and subseqently pelletized.
  • a preferred embodiment of the method according to the invention is characterized by the fact that the coating agent comprises up to 80%, preferably 60- 75% of a filler, which is a dry powder of any material, preferably an inorganic material, more preferably kaolin, magnesium silicate or calcium carbonate. Incorporation of the indicated filler into the coating agent in the amount indicated will reduce the tendency of the separate granules in the T-granulate to adhere to each other and to the granulating apparatus.
  • a preferred embodiment of the method according to the invention is characterized by the fact that the coating agent constitutes 1-95% w/w, preferably 15-35% w/w of the final, coated T-granulate. If an amount of coating agent below 1 % w/w is used no satisfactory enzyme stability improvement is obtained, and if an amount of coating agent above 95% is used, no further improvement of the enzyme stability is obtained.
  • a preferred embodiment of the method according to the invention is characterized by the fact that the T-granulate on top of the coating is coated once more with a polymeric material, preferably in a fluidized bed. In this manner the enzymatic stability is further improved.
  • Example 1 illustrates the use and the method according to the invention.
  • Example 2 illustrates a further advantage of the use according to the invention in relation to in vivo conditions.
  • This example illustrates the use according to the invention and the method according to the invention, in comparison to the prior art most related thereto.
  • the enzyme containing T-granulate related to both the use according to the invention and the method according to the invention is produced in the following manner, the granulate being identified as Bio-Feed Plus T.
  • the powder components for 20 kg of granulate are the following:
  • the above components are mixed in a 50 liter L ⁇ dige mixer, with heating to 35°C.
  • the mixing time is 2 minutes at a mixing velocity of the mixer paddles of 145 rpm and a knife rotating velocity of 3000 rpm.
  • liquid cellulase concentrate dry matter 40%, cellulase activity 764 EGU/g, the EGU activity unit being defined in AF-275, is sprinkled on the mixture.
  • the sprinkling is performed by means of an atomizing nozzle and with a sprinkling time of around 6 minutes. Subsequently the wet mixture is subjected to a further granulation for 2 minutes, until uniform sphere or lens formed granulates are obtained.
  • the humid granulate is dried in a fluid bed at an inlet temperature of 60°C, until a water content of less than 3% is obtained.
  • the particle size distribution of the dry granulate was: > 1200 ⁇ m 9.5% > 1000 ⁇ m 15.3%
  • the activity loss was less than 5%.
  • the dry granulate is coated with a total of 20 weight-% of hydrogenated beef tallow and 15.5 weight-% of magnesium silicate, in the following manner.
  • the dry, raw granulate is heated to 65°C, and subsequently 5 weight-% of hydrogenated beef tallow heated to 70°C is applied thereto, and thereafter 5.17% of magnesium silicate is applied thereto. These operations are repeated until the total amounts of hydrogenated beef tallow and magnesium silicate are added.
  • Bio-Feed Plus This is a granulate consisting of a fraction of wheat coated with enzymes. Reference can be made to the brochure B402C-GB 1500 October
  • Bio-Feed Plus tallow coated. This is Bio-Feed Plus coated with hydrogenated beef tallow in an amount of 20% 3) Cellulase T. This is a T-granulate with a fungal beta-glucanase and a cellulase, manufactured as indicated above in relation to the manufacture of Bio-Feed Plus
  • Cellulase P This is a prill product with a fungal beta-glucanase and a cellulase.
  • This product is prepared by mixing a melted fat with the spray dried enzymes.
  • the mixture of melted fat and the spray dried enzymes is sprayed into a chilled air stream, whereby the fat solidifies as droplets, whereby the enzymes are encapsulated in the fat.
  • composition of the fodder for small pigs were the following.
  • the animal fat was industrial waste fat.
  • the minerals + vitamins were added in the following amounts, calculated on 1 g of fodder:
  • choline chloride 25 ⁇ g Mn (manganese) 234 ⁇ g Fe (iron) 163 ⁇ g Cu (copper) 200 ⁇ g Zn (zinc)
  • the first four components of the above fodder for small pigs were mixed in a mill on a sieve with apertures of 2.0 mm, and then mixed with the two last components of the above fodder for small pigs in a 2500 liter horizontal mixer.
  • the finished meal mixture was used for the experiments in a pilot plant with batches of 100 kg.
  • This example illustrates an additional advantage of the use according to the invention compared to a traditionally used enzyme containing product, when used in a fodder for pigs.
  • Most enzymes are labile in acid environment and/or under the influence of proteolytic activity.
  • a significant loss of enzyme activity can often be expected after ingestion, when subjected to gastric conditions.
  • a good survival of enzyme activity from the gastric environment is necessary to prolong the effect of the enzymes over the gastro-intestinal tract.
  • This technique enables the estimation of the survival of enzyme activity after ingestion and passing through part of the gastro-intestinal tract of the pig.
  • the enzyme containing coated T-granulate was produced as indicated in US patent 4,106,991 by mixing sodium sulphate, cellulose, kaolin and dextrin in a high energy L ⁇ dige Mixer whereafter a liquid enzyme concentrate which was previously adjusted to approx. 700 EGU/g was sprayed onto the mixture whereby the proportions of sodium sulphate, cellulose, kaolin, dextrin and enzyme dry matter corresponds to the figures indicated below, and the amount of added water was just enough to generate correct granulation consistency and particle size distribution (reference being made to US 4,106,991, col. 2, lines 8-12).
  • the product was transferred to a fluidized bed and dried with hot air to reduce the water content to 1.0% (w/w).
  • the T-granulate was fractionated by sieving to a particle size between 300 ⁇ m and 1180 ⁇ m with respect to the particle diameter.
  • the T-granulate was then coated in a coating mixer by spraying with hydrogenated beef tallow and a filler, which is a premixed blend of equal parts of kaolin and calcium carbonate, in an alternate fashion.
  • the coating was performed as follows. First (in percentage of the uncoated T-granulate) 4% (w/w) of hydrogenated beef tallow was sprayed onto the mix, followed by addition of 12.5% (w/w) of the filler. This was followed by an analogous coating with 4% (w/w) hydrogenated beef tallow and 12.5% of the filler. A final coating with 1.5% hydrogenated beef tallow concluded the coating procedure.
  • the warm coated T-granualte was cooled in a fluidized bed with air at ambient temperature. During this process fines were removed.
  • the cooled enzyme containing coated T-granulate was finally fractionated by sieving to secure a particle size of between 300 ⁇ m and 1180 ⁇ m.
  • the composition of the enzyme free fodder used in the feeding experiments was:
  • the uses and the methods described in this example are not inside the scope of the invention, because the fodder is not pelletized.
  • the example will demonstrate an advantage of the use and method according to the invention over the prior art.
  • the reentrant cannulated pig which was used in the experiments was in both cases fed with a total of 610 g dry fodder as described above, mixed with 1525 g of water, as a single meal.
  • Two enzyme preparations were investigated: 1) "Bio- Feed Plus, coated T-granulate” produced as described above (according to the invention), and 2) "Bio-Feed Plus", a traditional product where the enzyme is coated onto a manna grit carrier (prior art).
  • the total intestinal content was continuously collected from the open cannula in separate pools. From each pool a representative sample of 15% was collected and freeze dried for later analysis. Then the remaining intestinal content after being heated to 40°C was pumped back to the intestine through the other half of the reentrant cannula. 20 After analyzing the specific beta-glucanase, pentosanase and xylanase activity in the samples obtained as described above the total survival of these exogenic enzyme actitivies can be calculated.
  • samples were extracted in the relevant buffer for each analysis by mixing 1 part of sample with 4 parts of buffer and stirring vigorously for 25 30 minutes. Subsequently the samples were centrifuged for 10 minutes at 3000 rpm, and the supernatant removed for analysis.
  • Glucanase activity was determined according to the procedure AF 295/1 - GB type feed.
  • Xylanase activity was determined according to the procedure AF 293.6.1 - 30 GB.
  • Pentosanase activity was determined according to the procedure AF 284/1 -GB. The results of the analysis is shown in the following table, which shows the total accumulated enzyme activity reaching the cannula in the small intestine eight hours after the feeding, indicated in percentage of the enzyme activity in the feed mix ingested by the animal.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Husbandry (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Fodder In General (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Glanulating (AREA)

Abstract

An enzyme containing T-granulate which is coated with a coating agent comprising a high melting fat or wax, is used as a component of a mixture, which is well suited as a fodder if the mixture is steam treated and subsequently pelletized. In the method for production of a pelletized fodder a mixture of an enzyme containing T-granulate, which is coated with a coating agent comprising a high melting fat or wax, and fodder components, is steam treated and subsequently pelletized. Hereby the enzyme stability during pelletizing is considerably improved in comparison to the prior art uses and methods.

Description

USE OF AN ENZYME CONTAINING GRANULATE AND METHOD FOR PRODUCTION OF A PELLETIZED FODDER
The invention comprises a use of an enzyme containing granulate and a method for production of a pelletized fodder. In the art comprising fodder it is described that the addition of enzymes to the fodder has a beneficial effect, vide e.g. Hesselman, K. and Aman P., The effect of ø-glucanase on the utilization of starch and nitrogen by broiler chickens fed on barley of low- or high-viscosity. Animal Feed Science and Technology, 15 (1986) 83- 93. Also, in the art comprising fodder it is a well known fact that pelletizing of the fodder is a desideratum, as pelletizing of the fodder increases the digestibility of especially the starch fraction. Furthermore, pelletizing of the fodder reduces the dust, it makes the fodder easier to eat for the birds, and it makes it possible to incorporate small amounts of ingredients in the fodder and to "lock" the fodder mixture. In the process of producing fodder pellets it is considered necessary to heat treat the fodder pellets in order to kill the Salmonella bacteria, whereby a heat treatment to around 80°C is appropriate. The enzymes are not stable at this high temperature, and thus, a large surplus of enzymes has to be used, or enzyme free fodder components have been pelletized and heat treated, whereafter an enzyme containing slurry or solution has been coated on the heat treated pellets. However, this coating is cumbersome and is often not compatible with existing plants. Thus, there is a need for an enzyme containing fodder which can be produced easier and by means of existing fodder producing plants.
The art encompassing enzyme containing granulates produced as additives in detergents comprises a socalled T-granulate, produced as indicated in US 4,106,991. A T-granulate which is coated with a wax, a triglyceride or other fat, is described in WO 89/08694, claims 12 and 1, EP 206,417, claims 17, 13, and 1 , and US 4,707,287, claims 1 and 14 and column 9, example II.
This coated T-granulate has been produced by coating of the T-granulate by a triglyceride instead of the traditional PEG. The above indicated, coated T-granulate is used as an additive in detergents, and to the best of applicant's knowledge this coated T-granulate has not been suggested for other uses than in the detergent field.
Surprisingly, according to the invention, it has now been found that the above indicated T-granulate can be used as a component of a mixture, which can be converted to a fodder by treatment with steam and pelletizing without appreciable loss of enzyme activity, in contradistinction to the prior art, in relation to which an appreciable loss of enzyme activity will take place during steam treatment and pelletizing. Thus, the use according to the invention of an enzyme containing T- granulate which is coated with a coating agent comprising a high melting fat or wax, is a use as a component of a mixture, which is well suited as a fodder if the mixture is steam treated and subsequently pelletized.
A T-granulate is a granulate produced according to US 4,106,991, i.e. a granulate containing 2-40% finely divided cellulose fibres. Also, it is to be understood that the T-granulate contains one or more of the enzymes, which can be used as additives to fodders. As typical examples can be mentioned: proteases, e.g. from Bacillus, for instance Bacillus licheniformis, xylanases, cellulases, beta-glucanases, e.g. from Bacillus, Humicola, for instance Humicola insolens, or Actinomycetes, pectinases, e.g. from Aspergillus, α-galactosidases, e.g. from Aspergillus, for instance Aspergillus niger, and amylases, e.g. from Bacillus, for instance Bacillus subtilis.
The coating agent comprises a high melting fat or wax. In this specification with claims a high melting fat is a glycerol ester (mono-, di- or triester or a mixture thereof) with a melting point between 30 and 100°C, and a high melting wax is a waxy substance according to the definition in US 4,106,991 , col. 3, lines 45- 50, i.e. a substance which possesses all of the following characteristics: (1) the melting point is between 30° and 100°C, preferably between 40° and 60°C, (2) the substance is of tough and not brittle nature, and (3) the substance possesses substantial plasticity at room temperature.
It appears from the applicant's EP 304,332 that the stability of the enzymes and the physical strength of the granules is improved, if a core is provided with a coating of cellulose fibres, a binder, an enzyme, a filler and a waxy material. It appears from DK 161717 that }-glucanases or α-amylases can be stabilized by adhesion to a solid carrier; such preparations can be used as ingredients in granulated fodders. It also appears from DE 3,520,007 and GB 2,167,758 that enzyme containing granulates can be coated with fats or waxes. On the basis of this prior art it apparently can be concluded that it is obvious that enzyme containing granulates coated with fat or wax in general are well suited as a component of a fodder mixture to be pelletized. This conclusion, however, is false, as it has been found that some enzyme containing granulates coated with fat or wax (e.g. fat coated Bio-Feed Plus, later to be characterized) are not well suited as a component of a fodder mixture to be pelletized.
Thus it is surprising that the use according to the invention gives rise to a stable fodder, because it already belongs to the prior art that Bio-Feed Plus (fraction of wheat coated with enzymes), fat coated Bio-Feed Plus, T-granulate not fat coated, and Cellulase P (prill enzyme preparation with high fat content) as a component of a mixture which is converted into a fodder does not give rise to a fodder with stable enzyme activity. These prior art phenomena will be documented later in this specification.
A preferred embodiment of the use according to the invention is characterized by the fact that the coating agent comprises up to 80%, preferably 60- 75% of a filler, which is a dry powder of any material, preferably an inorganic material, more preferably kaolin, magnesium silicate or calcium carbonate. Incorporation of the indicated filler into the coating agent in the amount indicated will reduce the tendency of the separate granules to adhere to each other and to the granulating apparatus.
A preferred embodiment of the use according to the invention is characterized by the fact that the coating agent constitutes 1-95% w/w, preferably 15-35% w/w of the final, coated T-granulate. If an amount of coating agent below 1 % w/w is used no satisfactory enzyme stability improvement is obtained, and if an amount of coating agent above 95% is used, no further improvement of the enzyme stability is obtained. A preferred embodiment of the use according to the invention is characterized by the fact that the T-granulate on top of the coating is coated once more with a polymeric material, preferably in a fluidized bed. In this manner the enzymatic stability is further improved. Also the invention comprises a method for production of a pelletized fodder, and this method is characterized by the fact that a mixture of an enzyme containing T-granulate, which is coated with a coating agent comprising a high melting fat or wax, and fodder components, is steam treated and subseqently pelletized. A preferred embodiment of the method according to the invention is characterized by the fact that the coating agent comprises up to 80%, preferably 60- 75% of a filler, which is a dry powder of any material, preferably an inorganic material, more preferably kaolin, magnesium silicate or calcium carbonate. Incorporation of the indicated filler into the coating agent in the amount indicated will reduce the tendency of the separate granules in the T-granulate to adhere to each other and to the granulating apparatus.
A preferred embodiment of the method according to the invention is characterized by the fact that the coating agent constitutes 1-95% w/w, preferably 15-35% w/w of the final, coated T-granulate. If an amount of coating agent below 1 % w/w is used no satisfactory enzyme stability improvement is obtained, and if an amount of coating agent above 95% is used, no further improvement of the enzyme stability is obtained.
A preferred embodiment of the method according to the invention is characterized by the fact that the T-granulate on top of the coating is coated once more with a polymeric material, preferably in a fluidized bed. In this manner the enzymatic stability is further improved.
The following examples illustrate the invention. Example 1 illustrates the use and the method according to the invention. Example 2 illustrates a further advantage of the use according to the invention in relation to in vivo conditions. EXAMPLE 1
This example illustrates the use according to the invention and the method according to the invention, in comparison to the prior art most related thereto. The enzyme containing T-granulate related to both the use according to the invention and the method according to the invention is produced in the following manner, the granulate being identified as Bio-Feed Plus T.
The powder components for 20 kg of granulate are the following:
2.0 kg of cellulose ARBOCEL BC 200 13.6 kg of ground sodium sulfate
0.6 kg of carbohydrate binder 1.2 kg of chalk
The above components are mixed in a 50 liter Lόdige mixer, with heating to 35°C. The mixing time is 2 minutes at a mixing velocity of the mixer paddles of 145 rpm and a knife rotating velocity of 3000 rpm.
Under the above indicated conditions 6.4 kg of liquid cellulase concentrate (dry matter 40%, cellulase activity 764 EGU/g, the EGU activity unit being defined in AF-275, is sprinkled on the mixture. The sprinkling is performed by means of an atomizing nozzle and with a sprinkling time of around 6 minutes. Subsequently the wet mixture is subjected to a further granulation for 2 minutes, until uniform sphere or lens formed granulates are obtained.
The humid granulate is dried in a fluid bed at an inlet temperature of 60°C, until a water content of less than 3% is obtained.
The particle size distribution of the dry granulate was: > 1200 μm 9.5% > 1000 μm 15.3%
> 850 μm 23.8%
> 707 μm 36.3% > 600 μm 51.1%
> 500 μm 66.4%
> 420 μm 73.8%
> 300 μm 88.9% < 250 μm 3.7%
The activity loss was less than 5%.
Subsequently the dry granulate is coated with a total of 20 weight-% of hydrogenated beef tallow and 15.5 weight-% of magnesium silicate, in the following manner. The dry, raw granulate is heated to 65°C, and subsequently 5 weight-% of hydrogenated beef tallow heated to 70°C is applied thereto, and thereafter 5.17% of magnesium silicate is applied thereto. These operations are repeated until the total amounts of hydrogenated beef tallow and magnesium silicate are added.
Then the granulate is cooled. Now the granulate is ready for use.
The following enzyme containing granulates representing the prior art most related to the invention were used as comparison granulates.
1) Bio-Feed Plus. This is a granulate consisting of a fraction of wheat coated with enzymes. Reference can be made to the brochure B402C-GB 1500 October
1990. 2) Bio-Feed Plus, tallow coated. This is Bio-Feed Plus coated with hydrogenated beef tallow in an amount of 20% 3) Cellulase T. This is a T-granulate with a fungal beta-glucanase and a cellulase, manufactured as indicated above in relation to the manufacture of Bio-Feed Plus
T. except for the fact that the coating is omitted 4) Cellulase P. This is a prill product with a fungal beta-glucanase and a cellulase.
This product is prepared by mixing a melted fat with the spray dried enzymes. The mixture of melted fat and the spray dried enzymes is sprayed into a chilled air stream, whereby the fat solidifies as droplets, whereby the enzymes are encapsulated in the fat. Reference can be made to the brochure B 495a-GB July
1989. These four reference granulates and the granulate used according to the invention were used for production of a pelletized fodder as follows.
The composition of the fodder for small pigs were the following.
7% fish meal 15% soy bean flakes
62% wheat 10% barley 2% animal fat minerals + vitamins
The animal fat was industrial waste fat.
The minerals + vitamins were added in the following amounts, calculated on 1 g of fodder:
50 μg of Olaquindox 100 μg of Toyocerin 16 i.u. of vitamin A
2 i.u. of vitamin D3 130 μg of vitamin E
4 μg of vitamin B2 20 μg of nicotinic acid 15 μg of D-pantothenic acid
0.02 μg of vitaimin B12 0.2 μg of biotin
2 μg of vitamin B,
2 μg of vitamin B6 2 μg of vitamin K_
100 μg choline chloride 25 μg Mn (manganese) 234 μg Fe (iron) 163 μg Cu (copper) 200 μg Zn (zinc)
0.3 μg J (iodine) 0.3 μg Se (selenium)
The first four components of the above fodder for small pigs were mixed in a mill on a sieve with apertures of 2.0 mm, and then mixed with the two last components of the above fodder for small pigs in a 2500 liter horizontal mixer. The finished meal mixture was used for the experiments in a pilot plant with batches of 100 kg.
In each experiment 10 kg of the above finished meal was mixed with 2 kg of any of the above indicated five granulates for 10 minutes in order to produce a premix. Then 88 kg of the above finished meal was mixed with the 12 kg of premix, thereby producing 100 kg of a mixture to be pelletized. The pelletizing procedure was performed at 70°C and with direct steam injection to a weight increase of 4%. The pelletizing process lasted for 25-30 seconds. Subsequently the pellets were cooled down to ambient temperature, and the pelletized product is now stable in regard to enzyme activity. The loss of enzyme activity takes place exclusively during the pelletizing process.
Determinations of residual activity were now carried out in regard to the five different pelletized materials. The results appear from the following table, in which FBG is fungal beta-glucanase, vide AF 70.1 /2-GB.
| Enzyme granulate % residual
I in fodder pellets FBG activity
| Bio-Feed Plus 75
Prior j Bio-Feed Plus, tallow coated 75 art j Cellulase T < 30 j Cellulase P 50
Invention I Bio-Feed Plus T 90-100
It clearly appears from the above table that the use and the method according to the invention is superior to the prior art uses and methods most closely related to the invention.
EXAMPLE 2
This example illustrates an additional advantage of the use according to the invention compared to a traditionally used enzyme containing product, when used in a fodder for pigs. Most enzymes are labile in acid environment and/or under the influence of proteolytic activity. Thus when adding enzymes to animal fodder a significant loss of enzyme activity can often be expected after ingestion, when subjected to gastric conditions. To achieve the optimal benefit of the added enzymes a good survival of enzyme activity from the gastric environment is necessary to prolong the effect of the enzymes over the gastro-intestinal tract.
In the two feeding experiments in this example the technique of reentrant cannulation of a grown pig of approx. 50 kg was used. Reference can be made to Horszczaruk. F. et al., "Roczniki nauk Rolniczych" 95 B4, 69-77 (1974) and Rainbird, A.L. et al., British Journal of Nutrition (1984), 52, 89-498, Effect of guar gum on glucose and water absorption from isolated loopes of jejenum in conscious growing pigs.
This technique enables the estimation of the survival of enzyme activity after ingestion and passing through part of the gastro-intestinal tract of the pig.
The enzyme containing coated T-granulate was produced as indicated in US patent 4,106,991 by mixing sodium sulphate, cellulose, kaolin and dextrin in a high energy Lόdige Mixer whereafter a liquid enzyme concentrate which was previously adjusted to approx. 700 EGU/g was sprayed onto the mixture whereby the proportions of sodium sulphate, cellulose, kaolin, dextrin and enzyme dry matter corresponds to the figures indicated below, and the amount of added water was just enough to generate correct granulation consistency and particle size distribution (reference being made to US 4,106,991, col. 2, lines 8-12).
After granulation the product was transferred to a fluidized bed and dried with hot air to reduce the water content to 1.0% (w/w).
In the T-granulate thus produced the percentage concentration (w/w) of the above dry ingredients were as follows:
Figure imgf000011_0001
After drying the T-granulate was fractionated by sieving to a particle size between 300 μm and 1180 μm with respect to the particle diameter.
The T-granulate was then coated in a coating mixer by spraying with hydrogenated beef tallow and a filler, which is a premixed blend of equal parts of kaolin and calcium carbonate, in an alternate fashion. The coating was performed as follows. First (in percentage of the uncoated T-granulate) 4% (w/w) of hydrogenated beef tallow was sprayed onto the mix, followed by addition of 12.5% (w/w) of the filler. This was followed by an analogous coating with 4% (w/w) hydrogenated beef tallow and 12.5% of the filler. A final coating with 1.5% hydrogenated beef tallow concluded the coating procedure.
After the coating the warm coated T-granualte was cooled in a fluidized bed with air at ambient temperature. During this process fines were removed.
The cooled enzyme containing coated T-granulate was finally fractionated by sieving to secure a particle size of between 300 μm and 1180 μm. The composition of the enzyme free fodder used in the feeding experiments was:
Oat bran: 67.71% (w/w)
Toasted soy flakes: 15.00% (w/w)
Wheat starch: 15.09% (w/w) Vitamin/mineral mix: 2.20% (w/w)
Formally, the uses and the methods described in this example are not inside the scope of the invention, because the fodder is not pelletized. However, due to the fact that a comparison is made between a coated T-granulate, which can be used according to the invention, and a granulate, which cannot be used according to the invention, the example will demonstrate an advantage of the use and method according to the invention over the prior art.
The reentrant cannulated pig which was used in the experiments was in both cases fed with a total of 610 g dry fodder as described above, mixed with 1525 g of water, as a single meal. Two enzyme preparations were investigated: 1) "Bio- Feed Plus, coated T-granulate" produced as described above (according to the invention), and 2) "Bio-Feed Plus", a traditional product where the enzyme is coated onto a manna grit carrier (prior art). Reference is made to the brochure B 402c-GB 1500, October 1990. in the first experiment 9.15 g of "Bio-Feed Plus, coated T-granulate" was 5 also added to the fodder and in the second experiment 6.1 g of "Bio-Feed Plus" was also added to the fodder, whereby the different gravimetric dosages correspond to equal dosages of enzyme activity.
In both cases the enzyme products were first mixed with the water and then mixed thoroughly with the dry fodder to ensure a homogenous mixture. 10 A small representative sample of this mixture was removed and freeze dried for later determination of enzyme activity in the fodder.
In these experiments the reentrant cannula was placed in the pig's small intestine approx. 3 m distal to the pancreatic gland.
Beginning immediately after the ingestion by the animal of the full amount 15 of the fodder the total intestinal content was continuously collected from the open cannula in separate pools. From each pool a representative sample of 15% was collected and freeze dried for later analysis. Then the remaining intestinal content after being heated to 40°C was pumped back to the intestine through the other half of the reentrant cannula. 20 After analyzing the specific beta-glucanase, pentosanase and xylanase activity in the samples obtained as described above the total survival of these exogenic enzyme actitivies can be calculated.
Before analysis the samples were extracted in the relevant buffer for each analysis by mixing 1 part of sample with 4 parts of buffer and stirring vigorously for 25 30 minutes. Subsequently the samples were centrifuged for 10 minutes at 3000 rpm, and the supernatant removed for analysis.
Glucanase activity was determined according to the procedure AF 295/1 - GB type feed.
Xylanase activity was determined according to the procedure AF 293.6.1 - 30 GB.
Pentosanase activity was determined according to the procedure AF 284/1 -GB. The results of the analysis is shown in the following table, which shows the total accumulated enzyme activity reaching the cannula in the small intestine eight hours after the feeding, indicated in percentage of the enzyme activity in the feed mix ingested by the animal.
Residual Residual Residual
Glucanase Xylanase Pentosanase
Activity (%) Activity (%) Activity (%)
Bio-Feed Plus, coated T-granulate 52 50 60
Bio-Feed Plus 28 27 38
It is thus surprisingly found that the residual glucanase, xylanase, and pentosanase activity in the first part of the pig's small intestine is significantly higher according to the invention than according to the prior art. The brochures and the AF documents referred to above are obtainable on request from Novo Nordisk A/S, Novo Allέ, DK-2880 Bagsvaerd, Denmark.

Claims

1. Use of an enzyme containing T-granulate which is coated with a coating agent comprising a high melting fat or wax, as a component of a mixture, which is well suited as a fodder if the mixture is steam treated and subsequently pelletized.
5 2. Use according to Claim 1 , wherein the coating agent comprises up to
80%, preferably 60-75% of a filler, which is a dry powder of any material, preferably an inorganic material, more preferably kaolin, magnesium silicate or calcium carbonate.
3. Use according to Claim 1 or 2, wherein the coating agent constitutes 1 - 10 95% w/w, preferably 15-35% w/w of the final, coated T-granulate.
4. Use according to Claims 1 - 3, wherein the T-granulate on top of the coating is coated once more with a polymeric material, preferably in a fluidized bed.
5. Method for production of a pelletized fodder, wherein a mixture of an enzyme containing T-granulate, which is coated with a coating agent comprising a
15 high melting fat or wax, and fodder components, is steam treated and subseqently pelletized.
6. Method according to Claim 5, wherein the coating agent comprises up to 80%, preferably 60-75% of a filler, which is a dry powder of any material, preferably an inorganic material, more preferably kaolin, magnesium silicate or 0 calcium carbonate.
7. Method according to Claims 5 - 6, wherein the coating agent constitutes 1-95% w/w, preferably 15-35% w/w of the final, coated T-granulate.
8. Method according to Claims 5 - 7, wherein the T-granulate on top of the coating is coated once more with a polymeric material, preferably in a fluidized bed.
PCT/DK1992/000026 1991-01-25 1992-01-24 Use of an enzyme containing granulate and method for production of a pelletized fodder WO1992012645A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP92904521A EP0569468B1 (en) 1991-01-25 1992-01-24 Use of an enzyme containing granulate and method for production of a pelletized fodder
US08/070,402 US5391371A (en) 1991-01-25 1992-01-24 Use of an enzyme containing granulate in a method for production of a pelletized fodder
DE69201952T DE69201952T2 (en) 1991-01-25 1992-01-24 USE OF ENZYME-BASED GRANULES AND METHOD FOR PRODUCING A PELLETIZED FEED.
JP50413192A JP3571336B2 (en) 1991-01-25 1992-01-24 Production method of pelletized feed

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK013491A DK13491D0 (en) 1991-01-25 1991-01-25 APPLICATION OF AN ENZYMOUS GRANULATE AND PROCEDURE FOR PREPARING A TABLET FORM
DK134/91 1991-01-25

Publications (1)

Publication Number Publication Date
WO1992012645A1 true WO1992012645A1 (en) 1992-08-06

Family

ID=8090128

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK1992/000026 WO1992012645A1 (en) 1991-01-25 1992-01-24 Use of an enzyme containing granulate and method for production of a pelletized fodder

Country Status (8)

Country Link
US (1) US5391371A (en)
EP (1) EP0569468B1 (en)
JP (2) JP3571336B2 (en)
AT (1) ATE120616T1 (en)
DE (1) DE69201952T2 (en)
DK (2) DK13491D0 (en)
ES (1) ES2070634T3 (en)
WO (1) WO1992012645A1 (en)

Cited By (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997016076A1 (en) * 1995-11-02 1997-05-09 Novo Nordisk A/S Feed enzyme preparations
WO1997042837A1 (en) * 1996-05-13 1997-11-20 Hoechst Aktiengesellschaft Enzyme pre-granules for granular fodder
EP0951836A2 (en) * 1998-04-22 1999-10-27 Filozoo S.p.A. Method for the preparation of medicated or integrated pre-mixtures for animal feeding
US6190591B1 (en) 1996-10-28 2001-02-20 General Mills, Inc. Embedding and encapsulation of controlled release particles
US6268329B1 (en) 1998-06-30 2001-07-31 Nouozymes A/S Enzyme containing granule
WO2002007529A2 (en) * 2000-07-22 2002-01-31 Syngenta Participations Ag Methods for high-temperature hydrolysis of galactose-containing oligosaccharides in complex mixtures
WO2002061427A1 (en) 2001-01-31 2002-08-08 Novozymes A/S Method of analysing granular composition by fluorescence analysis
US6436453B1 (en) 2000-06-16 2002-08-20 General Mills, Inc. Production of oil encapsulated minerals and vitamins in a glassy matrix
US6468568B1 (en) 2000-06-16 2002-10-22 General Mills, Inc. Oligosaccharide encapsulated mineral and vitamin ingredients
US6500426B1 (en) 1997-06-04 2002-12-31 Rudolf Carolus Maria Barendse Carbohydrate-based enzyme-containing granules for use in animal feed
US6500463B1 (en) 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
US6558718B1 (en) 2000-06-19 2003-05-06 General Mills, Inc. Nutrient clusters for food products and methods of preparation
WO2003080827A2 (en) 2002-03-27 2003-10-02 Novozymes A/S Granules with filamentous coatings
US6723358B1 (en) 1998-03-23 2004-04-20 General Mills, Inc. Encapsulation of components into edible products
WO2004033083A2 (en) 2002-10-09 2004-04-22 Novozymes A/S A method for improving particle compositions
WO2004067739A2 (en) 2003-01-27 2004-08-12 Novozymes A/S Stabilization of granules
EP1508281A1 (en) * 1999-06-25 2005-02-23 Basf Aktiengesellschaft Polymer-coated, granulated enzyme-containing feed additives and method for the production thereof
US6866860B2 (en) 2002-12-19 2005-03-15 Ethicon, Inc. Cationic alkyd polyesters for medical applications
US6872799B2 (en) 2002-12-18 2005-03-29 Ethicon, Inc. Functionalized polymers for medical applications
JP2005245431A (en) * 2004-03-04 2005-09-15 Microsoy Corp Toasted soybean flake and method for producing the same
EP1586241A1 (en) * 2004-04-16 2005-10-19 Paramelt B.V. Improved coating for stabilizing active ingredients
US6967234B2 (en) 2002-12-18 2005-11-22 Ethicon, Inc. Alkyd-lactone copolymers for medical applications
US7005136B2 (en) 2002-03-29 2006-02-28 Ethicon, Inc. Bone replacement materials utilizing bioabsorbable liquid polymers
US7026374B2 (en) 2002-06-25 2006-04-11 Aruna Nathan Injectable microdispersions for medical applications
US7030127B2 (en) 2001-06-29 2006-04-18 Ethicon, Inc. Composition and medical devices utilizing bioabsorbable polymeric waxes
US7034037B2 (en) 2001-06-29 2006-04-25 Ethicon, Inc. Compositions and medical devices utilizing bioabsorbable polymeric waxes and rapamycin
US7101566B2 (en) 2002-06-28 2006-09-05 Ethicon, Inc. Polymer coated microparticles for sustained release
US7186533B2 (en) 1999-02-10 2007-03-06 Basf Aktiengesellschaft Granulates containing feed-enzymes
WO2007031481A1 (en) * 2005-09-12 2007-03-22 Basf Aktiengesellschaft Method for producing solid enzyme granulates for animal food
WO2007031482A1 (en) * 2005-09-12 2007-03-22 Basf Aktiengesellschaft Granulates containing enzymes for animal food
WO2007044968A3 (en) * 2005-10-12 2007-06-07 Genencor Int Stable, durable granules with active agents
WO2007082693A2 (en) * 2006-01-17 2007-07-26 Ab Enzymes Gmbh Improved enzyme formulations for animal feed
WO2007098756A1 (en) 2006-03-02 2007-09-07 Novozymes A/S High capacity encapsulation process
US7326426B2 (en) 2002-03-29 2008-02-05 Ethicon, Inc. Compositions and medical devices utilizing bioabsorbable liquid polymers
WO2008017661A1 (en) 2006-08-07 2008-02-14 Novozymes A/S Enzyme granules for animal feed
EP1889904A2 (en) * 1999-10-01 2008-02-20 Novozymes A/S Enzyme granulate
US7368125B2 (en) 2002-06-05 2008-05-06 Ethicon, Inc. Amphiphilic polymers for medical applications
US7501269B2 (en) 2002-01-15 2009-03-10 Basf Aktiengesellschaft Granulates containing feed-enzymes
WO2009118329A1 (en) 2008-03-28 2009-10-01 Novozymes A/S Triggered release system
US7611877B2 (en) 2002-01-15 2009-11-03 Basf Aktiengesellschaft Granulates containing feed-enzymes
EP2143338A1 (en) 2004-09-27 2010-01-13 Novozymes A/S Enzyme Granules
US7803413B2 (en) 2005-10-31 2010-09-28 General Mills Ip Holdings Ii, Llc. Encapsulation of readily oxidizable components
WO2011000924A1 (en) 2009-07-03 2011-01-06 Abbott Products Gmbh Spray-dried amylase, pharmaceutical preparations comprising the same and use
EP2474235A2 (en) 2007-07-06 2012-07-11 Basf Se Process for producing corn gluten
WO2012110777A2 (en) 2011-02-18 2012-08-23 Dupont Nutrition Biosciences Aps Feed additive composition
WO2012110778A2 (en) 2011-02-18 2012-08-23 Dupont Nutrition Biosciences Aps Feed additive composition
WO2012110776A2 (en) 2011-02-18 2012-08-23 Dupont Nutrition Biosciences Aps Feed additive composition
EP2537918A1 (en) 2011-06-20 2012-12-26 The Procter & Gamble Company Consumer products with lipase comprising coated particles
WO2012175401A2 (en) 2011-06-20 2012-12-27 Novozymes A/S Particulate composition
US8802087B2 (en) 2004-03-22 2014-08-12 Abbott Products Gmbh Pharmaceutical compositions of lipase-containing products, in particular of pancreation
WO2014191170A1 (en) 2013-05-30 2014-12-04 Novozymes A/S Particulate enzyme composition
WO2015027258A2 (en) 2013-08-28 2015-03-05 Erber Aktiengesellschaft Polypeptide for the hydrolytic cleavage of zearalenone and/or zearalenone derivatives, isolated polynucleotide thereof, and additive containing polypeptide, use of said polypeptide and method
WO2015114112A1 (en) 2014-01-31 2015-08-06 Dupont Nutrition Biosciences Aps Protein
WO2015116395A1 (en) 2014-01-31 2015-08-06 Danisco Us Inc. Methods for improving by-products from fermentation processes using xylanase
US9179693B2 (en) 2012-08-03 2015-11-10 Dupont Nutrition Biosciences Aps Feed additive composition
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
WO2016070206A2 (en) 2014-11-07 2016-05-12 Erber Aktiengesellschaft Polypeptide for the enzymatic detoxification of zearalenone, isolated polynucleotide, and associated additive, use and method
WO2016134387A1 (en) 2015-02-24 2016-09-01 Erber Aktiengesellschaft Fusarium toxin-cleaving polypeptide variants, additives containing same, use of same, and method for splitting fusarium toxins
WO2016134985A1 (en) 2015-02-24 2016-09-01 Novozymes A/S Xylanase granules
EP3072399A1 (en) 2006-08-07 2016-09-28 Novozymes A/S Enzyme granules for animal feed
WO2016154640A1 (en) 2015-03-27 2016-10-06 Erber Aktiengesellschaft Use of a trichothecene-transforming alcohol dehydrogenase, method for transforming trichothecenes and trichothecene-transforming additive
WO2017040499A1 (en) 2015-09-02 2017-03-09 Dupont Nutrition Biosciences Aps Glycoside hydolases and their use in preventing and/or treating a pathogenic infection in an animal
WO2018005225A1 (en) 2016-06-30 2018-01-04 Danisco Us Inc Aspartic proteases
WO2018057420A1 (en) 2016-09-23 2018-03-29 Dupont Nutrition Biosciences Aps Use of low ph active alpha-1,4/1,6-glycoside hydrolases as a feed additive for ruminants to enhance starch digestion
WO2018118815A1 (en) 2016-12-21 2018-06-28 Dupont Nutrition Biosciences Aps Methods of using thermostable serine proteases
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
WO2018164876A1 (en) 2017-03-06 2018-09-13 Dupont Nutrition Biosciences Aps Novel fungal fucosidases and their use in preventing and/or treating a pathogenic infection in an animal
WO2018169750A1 (en) 2017-03-15 2018-09-20 Danisco Us Inc Trypsin-like serine proteases and uses thereof
WO2018169784A1 (en) 2017-03-15 2018-09-20 Dupont Nutrition Biosciences Aps Trypsin-like serine proteases and uses thereof cross-reference to related application
AU2017202595B2 (en) * 2005-10-12 2018-11-22 Genencor International, Inc. Stable, durable granules with active agents
WO2019156670A1 (en) 2018-02-08 2019-08-15 Danisco Us Inc. Thermally-resistant wax matrix particles for enzyme encapsulation
WO2019173424A1 (en) 2018-03-09 2019-09-12 Danisco Us Inc Glucoamylases and methods of use thereof
US10463701B2 (en) 2013-12-31 2019-11-05 DuPont Nutrition BioScience ApS Blends of Bacillus strains and enzymes
US10543464B2 (en) 2015-02-10 2020-01-28 Novozymes A/S Method for mixing of particles
WO2020053238A1 (en) 2018-09-11 2020-03-19 Novozymes A/S Stable granules for feed compositions
WO2020106796A1 (en) 2018-11-20 2020-05-28 Dupont Nutrition Biosciences Aps ENGINEERED ROBUST HIGH Tm-PHYTASE CLADE POLYPEPTIDES AND FRAGMENTS THEREOF
US10704037B2 (en) 2005-07-29 2020-07-07 Abbott Products Gmbh Processes for the manufacture and use of pancreatin
WO2021007379A1 (en) 2019-07-09 2021-01-14 Dupont Nutrition Biosciences Aps Fat coated particulate enzyme compositions
WO2021034660A1 (en) 2019-08-16 2021-02-25 Dupont Nutrition Biosciences Aps Compositions for gut health comprising combinations of lactobacillus strains
WO2021046073A1 (en) 2019-09-05 2021-03-11 Dupont Nutrition Biosciences Aps Feed composition
WO2021080864A2 (en) 2019-10-21 2021-04-29 Dupont Nutrition Biosciences Aps Compositions for gut health
WO2021102238A1 (en) 2019-11-20 2021-05-27 Dupont Nutrition Biosciences Aps Thermostable phytase variants
WO2021127360A1 (en) 2019-12-19 2021-06-24 Dupont Nutrition Biosciences Aps Diet formulations
WO2021158927A1 (en) 2020-02-07 2021-08-12 Dupont Nutrition Biosciences Aps Feed compositions for animal health
WO2021173974A1 (en) 2020-02-28 2021-09-02 Dupont Nutrition Biosciences Aps Feed compositions
WO2021212095A1 (en) 2020-04-17 2021-10-21 Danisco Us Inc. Glucoamylase and methods of use thereof
CN113786389A (en) * 2021-11-15 2021-12-14 北京挑战农业科技有限公司 Hot-melt coating method of granular enzyme preparation and application thereof
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
WO2022074166A1 (en) 2020-10-07 2022-04-14 Novozymes A/S New granules for animal feed
WO2022081947A1 (en) 2020-10-16 2022-04-21 Dupont Nutrition Biosciences Feed compositions for animal health
WO2022169933A2 (en) 2021-02-03 2022-08-11 Dupont Nutrition Biosciences Aps Compositions for gut health
WO2023049488A1 (en) 2021-09-27 2023-03-30 Dupont Nutrition Biosciences Aps Feed additive compositions and methods for using the same
WO2023064905A1 (en) 2021-10-15 2023-04-20 Danisco Us Inc. Glucoamylase variants and methods for use thereof
WO2023122676A1 (en) 2021-12-24 2023-06-29 Danisco Us Inc. Hybrid glucoamylases and methods of use thereof
WO2024064653A1 (en) 2022-09-20 2024-03-28 Dupont Nutrition Biosciences Aps Variant anti-viral polypeptides
US11981942B2 (en) 2013-07-23 2024-05-14 International N&H Denmark Aps Xylanases for solubilizing arabinoxylan-containing material
WO2024124013A1 (en) 2022-12-09 2024-06-13 International N&H Denmark Aps Feed formulations comprising a phytase for dairy ruminant animals

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19619222A1 (en) * 1996-05-13 1997-11-20 Solvay Enzymes Gmbh & Co Kg Enzyme granules for food technology applications
US5922343A (en) * 1996-07-03 1999-07-13 Stucker; Dennis R. Method of introducing carbohydrase enzymes to a ruminant feed for increasing the rate and extent of fiber digestion in the ruminant
GB9711831D0 (en) 1997-06-06 1997-08-06 Unilever Plc Cleaning compositions
US5871802A (en) * 1997-12-16 1999-02-16 Moorman Manufacturing Co. Animal feed pelleting process and animal feed pellets produced therefrom
EP0925723B1 (en) * 1997-12-23 2003-04-02 Cargill BV Protein-containing feedstuff and process for its manufacture
KR100260592B1 (en) 1998-02-24 2000-07-01 곽해수 Process for preparation for microencapsulated β-D-galactosidase using fatty acid ester and milk supplemented with it
EP0943242A1 (en) * 1998-02-26 1999-09-22 Puratos N.V. Granulated bread improver for the preparation of bakery products
US6383548B1 (en) 2000-07-07 2002-05-07 The United States Of America As Represented By The Secretary Of Agriculture Coby products and a process for their manufacture
DK1441599T3 (en) * 2001-10-26 2007-11-12 Novozymes As Manufacture of edible products
DE50301885D1 (en) * 2002-09-18 2006-01-12 Rettenmaier & Soehne Gmbh & Co FEED ADDITIVE AND FEED AGENT CONTAINING THEREOF
AU2003284625A1 (en) * 2002-11-22 2004-06-18 Kunimine Industries Co., Ltd. Granular composition and process for producing the same
NO319624B1 (en) * 2003-09-15 2005-09-05 Trouw Internat Bv Fish feed for salmonids in fresh water and use of such feed.
BRPI0515469A (en) * 2004-09-20 2008-07-22 Can Technologies Inc feed mineral supplement
DE102005043323A1 (en) * 2005-09-12 2007-03-15 Basf Ag Phytase-containing enzyme granules I
US8311738B2 (en) 2006-04-27 2012-11-13 Caterpillar Inc. Boom-mounted machine locating system
US8399230B2 (en) * 2006-10-12 2013-03-19 Kemin Industries, Inc. Heat-stable enzyme compositions
KR100954864B1 (en) * 2009-07-10 2010-04-28 대봉엘에스 주식회사 Pellet feed with excellent dissolution and digestibility for raising fish and its manufacturing process
CN103826614B (en) 2010-11-16 2018-04-13 普乐维美北美公司 Enteric coated sodium pyrosulfite poultry and livestock feed additive for vomitoxin removing toxic substances
US10743565B2 (en) 2013-10-02 2020-08-18 Can Technologies, Inc. Feed pellets and related systems and methods
WO2016028241A1 (en) * 2014-08-20 2016-02-25 Vaner Gida Ticaret Ve Sanayi Limited ŞIrketi Feed supplement covered with by-pass fat in order to increase milk yield and reproductive efficiency
DE202021102826U1 (en) 2021-05-25 2022-08-30 Johann Alpers Supplementary feed for farm animals and pets

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113626A1 (en) * 1982-12-20 1984-07-18 SANDERS, Société Anonyme dite: Process for stabilizing liquid enzymes, stabilized liquid enzymes and food containing such enzymes, especially for monogastric animals
DE3520007A1 (en) * 1984-06-04 1985-12-05 Mitsui Toatsu Chemicals, Inc., Tokio/Tokyo GRANULES, CONTAINING PHYSIOLOGICALLY ACTIVE SUBSTANCES, METHOD FOR THE PRODUCTION AND USE THEREOF
GB2167758A (en) * 1984-10-12 1986-06-04 Showa Denko Kk Enzyme-granulating method and granular composition containing enzyme
EP0257996A2 (en) * 1986-08-22 1988-03-02 Finnfeeds International Limited Feed premix and production method therefor
EP0276781A2 (en) * 1987-01-26 1988-08-03 Showa Denko Kabushiki Kaisha Granular agent for ruminant and production method thereof
EP0304332A2 (en) * 1987-08-21 1989-02-22 Novo Nordisk A/S Enzyme containing granulate and method for production thereof
WO1989008694A1 (en) * 1988-03-14 1989-09-21 Novo-Nordisk A/S Granulate detergent enzyme product, method for production thereof, use thereof, and detergent containing such product

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113626A1 (en) * 1982-12-20 1984-07-18 SANDERS, Société Anonyme dite: Process for stabilizing liquid enzymes, stabilized liquid enzymes and food containing such enzymes, especially for monogastric animals
DE3520007A1 (en) * 1984-06-04 1985-12-05 Mitsui Toatsu Chemicals, Inc., Tokio/Tokyo GRANULES, CONTAINING PHYSIOLOGICALLY ACTIVE SUBSTANCES, METHOD FOR THE PRODUCTION AND USE THEREOF
GB2167758A (en) * 1984-10-12 1986-06-04 Showa Denko Kk Enzyme-granulating method and granular composition containing enzyme
EP0257996A2 (en) * 1986-08-22 1988-03-02 Finnfeeds International Limited Feed premix and production method therefor
EP0276781A2 (en) * 1987-01-26 1988-08-03 Showa Denko Kabushiki Kaisha Granular agent for ruminant and production method thereof
EP0304332A2 (en) * 1987-08-21 1989-02-22 Novo Nordisk A/S Enzyme containing granulate and method for production thereof
WO1989008694A1 (en) * 1988-03-14 1989-09-21 Novo-Nordisk A/S Granulate detergent enzyme product, method for production thereof, use thereof, and detergent containing such product

Cited By (134)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997016076A1 (en) * 1995-11-02 1997-05-09 Novo Nordisk A/S Feed enzyme preparations
WO1997042837A1 (en) * 1996-05-13 1997-11-20 Hoechst Aktiengesellschaft Enzyme pre-granules for granular fodder
US6221406B1 (en) 1996-05-13 2001-04-24 Beate Meschonat Enzyme pre-granules for granular fodder
US6190591B1 (en) 1996-10-28 2001-02-20 General Mills, Inc. Embedding and encapsulation of controlled release particles
US7611701B2 (en) 1997-06-04 2009-11-03 Basf Aktiengesellschaft Preparation of phytase-containing granulates for use in animal feed
US6500426B1 (en) 1997-06-04 2002-12-31 Rudolf Carolus Maria Barendse Carbohydrate-based enzyme-containing granules for use in animal feed
US8313757B2 (en) 1998-03-23 2012-11-20 General Mills, Inc. Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles
US6723358B1 (en) 1998-03-23 2004-04-20 General Mills, Inc. Encapsulation of components into edible products
EP0951836A2 (en) * 1998-04-22 1999-10-27 Filozoo S.p.A. Method for the preparation of medicated or integrated pre-mixtures for animal feeding
EP0951836A3 (en) * 1998-04-22 2000-05-03 Filozoo S.p.A. Method for the preparation of medicated or integrated pre-mixtures for animal feeding
US6268329B1 (en) 1998-06-30 2001-07-31 Nouozymes A/S Enzyme containing granule
US6348442B2 (en) 1998-06-30 2002-02-19 Novozymes A/S Enzyme containing granule
US7186533B2 (en) 1999-02-10 2007-03-06 Basf Aktiengesellschaft Granulates containing feed-enzymes
EP1508281A1 (en) * 1999-06-25 2005-02-23 Basf Aktiengesellschaft Polymer-coated, granulated enzyme-containing feed additives and method for the production thereof
US7556802B1 (en) 1999-06-25 2009-07-07 Basf Se Polymer-coated, granulated enzyme-containing feed additives and method for the production thereof
EP1889904A2 (en) * 1999-10-01 2008-02-20 Novozymes A/S Enzyme granulate
US6500463B1 (en) 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
US6468568B1 (en) 2000-06-16 2002-10-22 General Mills, Inc. Oligosaccharide encapsulated mineral and vitamin ingredients
US6436453B1 (en) 2000-06-16 2002-08-20 General Mills, Inc. Production of oil encapsulated minerals and vitamins in a glassy matrix
US6558718B1 (en) 2000-06-19 2003-05-06 General Mills, Inc. Nutrient clusters for food products and methods of preparation
WO2002007529A3 (en) * 2000-07-22 2002-09-19 Syngenta Participations Ag Methods for high-temperature hydrolysis of galactose-containing oligosaccharides in complex mixtures
WO2002007529A2 (en) * 2000-07-22 2002-01-31 Syngenta Participations Ag Methods for high-temperature hydrolysis of galactose-containing oligosaccharides in complex mixtures
WO2002061427A1 (en) 2001-01-31 2002-08-08 Novozymes A/S Method of analysing granular composition by fluorescence analysis
US7030127B2 (en) 2001-06-29 2006-04-18 Ethicon, Inc. Composition and medical devices utilizing bioabsorbable polymeric waxes
US7034037B2 (en) 2001-06-29 2006-04-25 Ethicon, Inc. Compositions and medical devices utilizing bioabsorbable polymeric waxes and rapamycin
EP1467630B2 (en) 2002-01-15 2011-04-20 Basf Se Granulates containing feed-enzymes
US7501269B2 (en) 2002-01-15 2009-03-10 Basf Aktiengesellschaft Granulates containing feed-enzymes
US7611877B2 (en) 2002-01-15 2009-11-03 Basf Aktiengesellschaft Granulates containing feed-enzymes
WO2003080827A2 (en) 2002-03-27 2003-10-02 Novozymes A/S Granules with filamentous coatings
US7005136B2 (en) 2002-03-29 2006-02-28 Ethicon, Inc. Bone replacement materials utilizing bioabsorbable liquid polymers
US7326426B2 (en) 2002-03-29 2008-02-05 Ethicon, Inc. Compositions and medical devices utilizing bioabsorbable liquid polymers
US8623413B2 (en) 2002-03-29 2014-01-07 Ethicon, Inc. Compositions and medical devices utilizing bioabsorbable liquid polymers
US7368125B2 (en) 2002-06-05 2008-05-06 Ethicon, Inc. Amphiphilic polymers for medical applications
US7026374B2 (en) 2002-06-25 2006-04-11 Aruna Nathan Injectable microdispersions for medical applications
US7101566B2 (en) 2002-06-28 2006-09-05 Ethicon, Inc. Polymer coated microparticles for sustained release
WO2004033083A2 (en) 2002-10-09 2004-04-22 Novozymes A/S A method for improving particle compositions
US6967234B2 (en) 2002-12-18 2005-11-22 Ethicon, Inc. Alkyd-lactone copolymers for medical applications
US6872799B2 (en) 2002-12-18 2005-03-29 Ethicon, Inc. Functionalized polymers for medical applications
US6866860B2 (en) 2002-12-19 2005-03-15 Ethicon, Inc. Cationic alkyd polyesters for medical applications
WO2004067739A2 (en) 2003-01-27 2004-08-12 Novozymes A/S Stabilization of granules
JP2005245431A (en) * 2004-03-04 2005-09-15 Microsoy Corp Toasted soybean flake and method for producing the same
US8802087B2 (en) 2004-03-22 2014-08-12 Abbott Products Gmbh Pharmaceutical compositions of lipase-containing products, in particular of pancreation
EP1586241A1 (en) * 2004-04-16 2005-10-19 Paramelt B.V. Improved coating for stabilizing active ingredients
EP2160950A1 (en) 2004-09-27 2010-03-10 Novozymes A/S Enzyme granules
DE202005021811U1 (en) 2004-09-27 2010-04-15 Novozymes A/S Granules with a core and a coating
EP2258209A1 (en) 2004-09-27 2010-12-08 Novozymes A/S Enzyme Granules
DE202005021810U1 (en) 2004-09-27 2010-04-22 Novozymes A/S Granules with a core and a coating
EP2143338A1 (en) 2004-09-27 2010-01-13 Novozymes A/S Enzyme Granules
EP2143339A1 (en) 2004-09-27 2010-01-13 Novozymes A/S Enzyme Granules
US10704037B2 (en) 2005-07-29 2020-07-07 Abbott Products Gmbh Processes for the manufacture and use of pancreatin
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
WO2007031482A1 (en) * 2005-09-12 2007-03-22 Basf Aktiengesellschaft Granulates containing enzymes for animal food
WO2007031481A1 (en) * 2005-09-12 2007-03-22 Basf Aktiengesellschaft Method for producing solid enzyme granulates for animal food
AU2017202595B2 (en) * 2005-10-12 2018-11-22 Genencor International, Inc. Stable, durable granules with active agents
WO2007044968A3 (en) * 2005-10-12 2007-06-07 Genencor Int Stable, durable granules with active agents
AU2006299824B2 (en) * 2005-10-12 2012-10-25 Genencor International, Inc. Stable, durable granules with active agents
EP2497378A3 (en) * 2005-10-12 2013-09-04 Danisco US Inc. Stable, durable granules with active agents
EP2497376A3 (en) * 2005-10-12 2013-01-02 Danisco US Inc. Stable, durable granules with active agents
US8142831B2 (en) 2005-10-31 2012-03-27 General Mills Ip Holdings Ii, Llc Encapsulation of readily oxidizable components
US7803414B2 (en) 2005-10-31 2010-09-28 General Mills Ip Holdings Ii, Llc Encapsulation of readily oxidizable components
US7803413B2 (en) 2005-10-31 2010-09-28 General Mills Ip Holdings Ii, Llc. Encapsulation of readily oxidizable components
WO2007082693A3 (en) * 2006-01-17 2007-09-07 Syngenta Ltd Improved enzyme formulations for animal feed
WO2007082693A2 (en) * 2006-01-17 2007-07-26 Ab Enzymes Gmbh Improved enzyme formulations for animal feed
EP1974030B1 (en) 2006-01-17 2016-09-14 AB Enzymes GmbH Improved enzyme formulations for animal feed
WO2007098756A1 (en) 2006-03-02 2007-09-07 Novozymes A/S High capacity encapsulation process
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US9578891B2 (en) 2006-08-07 2017-02-28 Novozymes A/S Enzyme granules for animal feed
US12108776B2 (en) 2006-08-07 2024-10-08 Novozymes A/S Enzyme granules for animal feed
US11229223B2 (en) 2006-08-07 2022-01-25 Novozymes A/S Enzyme granules for animal feed
WO2008017661A1 (en) 2006-08-07 2008-02-14 Novozymes A/S Enzyme granules for animal feed
EP3072399A1 (en) 2006-08-07 2016-09-28 Novozymes A/S Enzyme granules for animal feed
EP2474235A2 (en) 2007-07-06 2012-07-11 Basf Se Process for producing corn gluten
WO2009118329A1 (en) 2008-03-28 2009-10-01 Novozymes A/S Triggered release system
WO2011000924A1 (en) 2009-07-03 2011-01-06 Abbott Products Gmbh Spray-dried amylase, pharmaceutical preparations comprising the same and use
WO2012110778A2 (en) 2011-02-18 2012-08-23 Dupont Nutrition Biosciences Aps Feed additive composition
US11172693B2 (en) 2011-02-18 2021-11-16 Dupont Nutrition Biosciences Aps Feed additive composition
WO2012110777A2 (en) 2011-02-18 2012-08-23 Dupont Nutrition Biosciences Aps Feed additive composition
US10695384B2 (en) 2011-02-18 2020-06-30 Dupont Nutrition Biosciences Aps Feed additive composition
WO2012110776A2 (en) 2011-02-18 2012-08-23 Dupont Nutrition Biosciences Aps Feed additive composition
WO2012175401A2 (en) 2011-06-20 2012-12-27 Novozymes A/S Particulate composition
EP2537918A1 (en) 2011-06-20 2012-12-26 The Procter & Gamble Company Consumer products with lipase comprising coated particles
WO2013003025A1 (en) 2011-06-20 2013-01-03 The Procter & Gamble Company Consumer products with lipase comprising coated particles
US10149891B2 (en) 2012-08-03 2018-12-11 Dupont Nutrition Biosciences Aps Feed additive composition
US11235035B2 (en) 2012-08-03 2022-02-01 Dupont Nutrition Biosciences Aps Feed additive composition
US9179693B2 (en) 2012-08-03 2015-11-10 Dupont Nutrition Biosciences Aps Feed additive composition
WO2014191170A1 (en) 2013-05-30 2014-12-04 Novozymes A/S Particulate enzyme composition
US11981942B2 (en) 2013-07-23 2024-05-14 International N&H Denmark Aps Xylanases for solubilizing arabinoxylan-containing material
WO2015027258A2 (en) 2013-08-28 2015-03-05 Erber Aktiengesellschaft Polypeptide for the hydrolytic cleavage of zearalenone and/or zearalenone derivatives, isolated polynucleotide thereof, and additive containing polypeptide, use of said polypeptide and method
WO2015027259A2 (en) 2013-08-28 2015-03-05 Erber Aktiengesellchaft Polypeptide for the hydrolytic cleavage of zearalenone and/or zearalenone derivatives, isolated polynucleotide thereof, and additive containing polypeptide, use of said polypeptide and method
US10463701B2 (en) 2013-12-31 2019-11-05 DuPont Nutrition BioScience ApS Blends of Bacillus strains and enzymes
WO2015116395A1 (en) 2014-01-31 2015-08-06 Danisco Us Inc. Methods for improving by-products from fermentation processes using xylanase
EP3702450A1 (en) 2014-01-31 2020-09-02 DuPont Nutrition Biosciences ApS Protein
WO2015114112A1 (en) 2014-01-31 2015-08-06 Dupont Nutrition Biosciences Aps Protein
WO2016070206A2 (en) 2014-11-07 2016-05-12 Erber Aktiengesellschaft Polypeptide for the enzymatic detoxification of zearalenone, isolated polynucleotide, and associated additive, use and method
US10543464B2 (en) 2015-02-10 2020-01-28 Novozymes A/S Method for mixing of particles
WO2016134985A1 (en) 2015-02-24 2016-09-01 Novozymes A/S Xylanase granules
WO2016134387A1 (en) 2015-02-24 2016-09-01 Erber Aktiengesellschaft Fusarium toxin-cleaving polypeptide variants, additives containing same, use of same, and method for splitting fusarium toxins
US10264807B2 (en) 2015-02-24 2019-04-23 Erber Aktiengesellschaft Fusarium toxin-cleaving polypeptide variants, additive containing same, use of same, and method for splitting fusarium toxins
WO2016154640A1 (en) 2015-03-27 2016-10-06 Erber Aktiengesellschaft Use of a trichothecene-transforming alcohol dehydrogenase, method for transforming trichothecenes and trichothecene-transforming additive
US10526585B2 (en) 2015-03-27 2020-01-07 Erber Aktiengesellschaft Trichothecene-transforming alcohol dehydrogenase, method for transforming trichothecenes and trichothecene-transforming additive
US11001812B2 (en) 2015-03-27 2021-05-11 Erber Aktiengesellschaft Trichothecene-transforming alcohol dehydrogenase, method for transforming trichothecenes and trichothecene-transforming additive
WO2017040499A1 (en) 2015-09-02 2017-03-09 Dupont Nutrition Biosciences Aps Glycoside hydolases and their use in preventing and/or treating a pathogenic infection in an animal
EP3711773A1 (en) 2015-09-02 2020-09-23 DuPont Nutrition Biosciences ApS Glycoside hydrolases and their use in preventing and/or treating a pathogenic infection in an animal
EP3825399A1 (en) 2016-06-30 2021-05-26 Danisco US Inc. Aspartic proteases
WO2018005225A1 (en) 2016-06-30 2018-01-04 Danisco Us Inc Aspartic proteases
WO2018057420A1 (en) 2016-09-23 2018-03-29 Dupont Nutrition Biosciences Aps Use of low ph active alpha-1,4/1,6-glycoside hydrolases as a feed additive for ruminants to enhance starch digestion
WO2018118815A1 (en) 2016-12-21 2018-06-28 Dupont Nutrition Biosciences Aps Methods of using thermostable serine proteases
WO2018164876A1 (en) 2017-03-06 2018-09-13 Dupont Nutrition Biosciences Aps Novel fungal fucosidases and their use in preventing and/or treating a pathogenic infection in an animal
WO2018169784A1 (en) 2017-03-15 2018-09-20 Dupont Nutrition Biosciences Aps Trypsin-like serine proteases and uses thereof cross-reference to related application
WO2018169750A1 (en) 2017-03-15 2018-09-20 Danisco Us Inc Trypsin-like serine proteases and uses thereof
WO2019156670A1 (en) 2018-02-08 2019-08-15 Danisco Us Inc. Thermally-resistant wax matrix particles for enzyme encapsulation
US11525151B2 (en) 2018-03-09 2022-12-13 Danisco Us Inc. Glucoamylases and methods of use, thereof
WO2019173424A1 (en) 2018-03-09 2019-09-12 Danisco Us Inc Glucoamylases and methods of use thereof
WO2020053238A1 (en) 2018-09-11 2020-03-19 Novozymes A/S Stable granules for feed compositions
WO2020106796A1 (en) 2018-11-20 2020-05-28 Dupont Nutrition Biosciences Aps ENGINEERED ROBUST HIGH Tm-PHYTASE CLADE POLYPEPTIDES AND FRAGMENTS THEREOF
WO2021007379A1 (en) 2019-07-09 2021-01-14 Dupont Nutrition Biosciences Aps Fat coated particulate enzyme compositions
WO2021034660A1 (en) 2019-08-16 2021-02-25 Dupont Nutrition Biosciences Aps Compositions for gut health comprising combinations of lactobacillus strains
WO2021046073A1 (en) 2019-09-05 2021-03-11 Dupont Nutrition Biosciences Aps Feed composition
WO2021080864A2 (en) 2019-10-21 2021-04-29 Dupont Nutrition Biosciences Aps Compositions for gut health
WO2021102238A1 (en) 2019-11-20 2021-05-27 Dupont Nutrition Biosciences Aps Thermostable phytase variants
WO2021127360A1 (en) 2019-12-19 2021-06-24 Dupont Nutrition Biosciences Aps Diet formulations
WO2021158927A1 (en) 2020-02-07 2021-08-12 Dupont Nutrition Biosciences Aps Feed compositions for animal health
WO2021173974A1 (en) 2020-02-28 2021-09-02 Dupont Nutrition Biosciences Aps Feed compositions
WO2021212095A1 (en) 2020-04-17 2021-10-21 Danisco Us Inc. Glucoamylase and methods of use thereof
WO2022074166A1 (en) 2020-10-07 2022-04-14 Novozymes A/S New granules for animal feed
WO2022081947A1 (en) 2020-10-16 2022-04-21 Dupont Nutrition Biosciences Feed compositions for animal health
WO2022169933A2 (en) 2021-02-03 2022-08-11 Dupont Nutrition Biosciences Aps Compositions for gut health
WO2023049488A1 (en) 2021-09-27 2023-03-30 Dupont Nutrition Biosciences Aps Feed additive compositions and methods for using the same
WO2023064905A1 (en) 2021-10-15 2023-04-20 Danisco Us Inc. Glucoamylase variants and methods for use thereof
CN113786389A (en) * 2021-11-15 2021-12-14 北京挑战农业科技有限公司 Hot-melt coating method of granular enzyme preparation and application thereof
WO2023122676A1 (en) 2021-12-24 2023-06-29 Danisco Us Inc. Hybrid glucoamylases and methods of use thereof
WO2024064653A1 (en) 2022-09-20 2024-03-28 Dupont Nutrition Biosciences Aps Variant anti-viral polypeptides
WO2024124013A1 (en) 2022-12-09 2024-06-13 International N&H Denmark Aps Feed formulations comprising a phytase for dairy ruminant animals

Also Published As

Publication number Publication date
JP3756915B2 (en) 2006-03-22
DK13491D0 (en) 1991-01-25
DE69201952D1 (en) 1995-05-11
JP3571336B2 (en) 2004-09-29
JPH06504911A (en) 1994-06-09
ATE120616T1 (en) 1995-04-15
DE69201952T2 (en) 1995-11-23
JP2004222734A (en) 2004-08-12
EP0569468B1 (en) 1995-04-05
US5391371A (en) 1995-02-21
EP0569468A1 (en) 1993-11-18
ES2070634T3 (en) 1995-06-01
DK0569468T3 (en) 1995-08-07

Similar Documents

Publication Publication Date Title
US5391371A (en) Use of an enzyme containing granulate in a method for production of a pelletized fodder
EP1926393B1 (en) Enzyme granulate i containing phytase
CA2636522C (en) Improved enzyme formulations for animal feed
CA2292955C (en) Carbohydrate-based enzyme granulates
EP1189518B1 (en) Polymer-coated, granulated enzyme-containing feed additives and method for the production thereof
EP2163161B1 (en) Enzyme Granules
KR100888114B1 (en) Stabilized Phosphatase Formulations
JP2002536005A (en) Granules containing feed enzymes
CN101291592A (en) Phytase-containing enzyme granulate ii
WO2007031481A1 (en) Method for producing solid enzyme granulates for animal food
AU2008285608B2 (en) Heat-resistant composition for animals, comprising an enzymatic mixture
EP1933636A1 (en) Granulates containing enzymes for animal food
BR112021004688A2 (en) stable granules for feed compositions
MXPA00009822A (en) Granulates containing feed-enzymes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

WWE Wipo information: entry into national phase

Ref document number: 08070402

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 1992904521

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1992904521

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1992904521

Country of ref document: EP